Mizuho analyst Graig Suvannavejh upgraded Belite Bio (BLTE) to Outperform from Neutral with a $194 price target
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLTE:
- Belite Bio TBA Spot Secondary; price range $150.00-$154.00
- Belite Bio Reports Increased Cash Reserves Amid Rising R&D Costs
- Belite Bio Announces Public Offering of ADSs to Fund Expansion
- Belite Bio announces American Depositary shares offering, no amount given
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!